New coronavirus disease (COVID-19) and cardiovascular disease

Abstract

The management of these patients requires healthcare professionals to have specific knowledge on the characteristics of the viral infection, its clinical signs and symptoms combined with cardiovascular diseases, as well as individual and collective prevention measures. The safety of healthcare professionals and favorable prognosis of patients are of the top priority for the modern healthcare system.The review discusses current challenges associated with the novel coronavirus disease COVID-19 and cardiovascular diseases. The results of few clinical trials and individual case reports have shown the presence of certain problems in treating patients with comorbidity and viral infection. The new data on the drug interactions are reported. Common patterns of typical cardiovascular diseases and COVID-19 are presented. The risk groups with the need for timely diagnosis and intensive cardiac care are identified to prevent adverse outcomes in patients with this comorbidity.